Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Richman Eric I

SEC-identified person · CIK 1313876 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Gain Therapeutics, Inc. GANX Director · Chief Executive Officer filed 2021 - 2025
Ohr Pharmaceutical Inc OHRP Director filed 2019 - 2022
R&R Acquisition VI, INC ADMA Director filed 2012 - 2020
Pharmathene, INC PIP Director · Sr. VP, Business Development filed 2007 - 2016
Lev Pharmaceuticals Inc LEVP.OB Director filed 2007 - 2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.